Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 73.52 trillion as of August 14, 2025. Its market cap has increased by 25.36% in one year.

Market Cap

73.52T

Enterprise Value

73.66T

Revenue

4.90T

Ranking

n/a

PE Ratio

57.46

Stock Price

1,033,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 73.52T, an increase of 671.67%. That is a compound annual growth rate of 26.27%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	74.02T	9.59%
Dec 30, 2024	67.54T	24.87%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	54.65T	90.76%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion	38.80T
ALTEOGEN	24.00T
Yuhan	8,487.38B
Peptron	8,130.78B
SK Biopharmaceuticals	7,846.99B
PharmaResearch	6,909.12B
LigaChem Biosciences	5,648.08B
HLB Co., Ltd.	5,476.74B

Market Cap Rankings